A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib
Authors:
- 27 November 2019
- journal article
- letter
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (7) , 1773-1775
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Gastrointestinal Involvement of Systemic Vasculitis2019
- Takayasu ArteritisFrontiers in Pediatrics, 2018
- Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel VasculitisCirculation, 2018
- Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)Annals of the Rheumatic Diseases, 2018
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2017
- Brief Report: Takayasu Arteritis and Ulcerative Colitis: High Rate of Co‐Occurrence and Genetic OverlapArthritis & Rheumatology, 2015
- Recent advances in Takayasu arteritisInternational Journal of Rheumatic Diseases, 2014
- Recent advances in the medical management of Takayasu arteritisCurrent Opinion in Rheumatology, 2014